Literature DB >> 8654628

Evidence for diminished midcycle ovarian androgen production in older reproductive aged women.

T Mushayandebvu1, V D Castracane, T Gimpel, T Adel, N Santoro.   

Abstract

OBJECTIVE: To test the hypothesis that reproductive aging is associated with menstrual cycle-related decreases in androgen secretion.
DESIGN: Comparison of cross-sectional data.
SETTING: University teaching hospital. PATIENTS: Two groups of seven women were studied; midreproductive aged (19 to 37 years old) and older reproductive aged (43 to 47 years old). All patients were cycling regularly and had normal PRL and TSH.
INTERVENTIONS: Patients underwent blood sampling during selected days of the menstrual cycle. MAIN OUTCOME MEASURE: After establishing the date of the midcycle surge, specimens were measured on selected days for androstenedione (A), total T, free T, and sex hormone-binding globulin (SHBG) using commercially available reagents.
RESULTS: Sex hormone-binding concentrations did not vary across the menstrual cycle and did not differ between older and younger women. Total T did not differ significantly at any cycle stage between older and younger women. However, the midcycle rise in free T and A seen in younger women was consistently and significantly absent in the older women.
CONCLUSIONS: In the absence of significant changes in SHBG associated with older reproductive age, the finding of diminished concentrations of both free T and A suggests that these hormones are produced in lesser quantity at midcycle in older women. Because the changes we noted depended on menstrual cycle stage, our findings suggest that an ovarian and not adrenal process is involved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654628     DOI: 10.1016/s0015-0282(16)58203-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  First assessment of menstrual cycle function and reproductive endocrine status in Samoan women.

Authors:  G Lambert-Messerlian; M B Roberts; S S Urlacher; J Ah-Ching; S Viali; M Urbanek; S T McGarvey
Journal:  Hum Reprod       Date:  2011-06-15       Impact factor: 6.918

2.  Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study.

Authors:  Tess V Clendenen; Kathryn Hertzmark; Karen L Koenig; Eva Lundin; Sabina Rinaldi; Theron Johnson; Vittorio Krogh; Göran Hallmans; Annika Idahl; Annekatrin Lukanova; Anne Zeleniuch-Jacquotte
Journal:  Horm Cancer       Date:  2016-02-29       Impact factor: 3.869

3.  Androgen replacement for women.

Authors:  R Basson
Journal:  Can Fam Physician       Date:  1999-09       Impact factor: 3.275

Review 4.  Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.

Authors:  Crystal C Lipsey; Adriana Harbuzariu; Danielle Daley-Brown; Ruben R Gonzalez-Perez
Journal:  World J Methodol       Date:  2016-03-26

Review 5.  Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.

Authors:  S N Seidman
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

6.  Steroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide-treated mice.

Authors:  Zelieann Rivera; Patricia J Christian; Sam L Marion; Heddwen L Brooks; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2008-10-01       Impact factor: 4.285

7.  Retaining Residual Ovarian Tissue following Ovarian Failure Has Limited Influence on Bone Loss in Aged Mice.

Authors:  Zelieann R Craig; Samuel L Marion; Janet L Funk; Mary L Bouxsein; Patricia B Hoyer
Journal:  J Osteoporos       Date:  2010-06-29

8.  Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls.

Authors:  Jessica Rieder; Nanette Santoro; Hillel W Cohen; Paul Marantz; Susan M Coupey
Journal:  J Adolesc Health       Date:  2008-05-19       Impact factor: 5.012

9.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

10.  Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Alessandro Conforti; Sandro C Esteves; Peter Humaidan; Salvatore Longobardi; Thomas D'Hooghe; Raoul Orvieto; Alberto Vaiarelli; Danilo Cimadomo; Laura Rienzi; Filippo Maria Ubaldi; Fulvio Zullo; Carlo Alviggi
Journal:  Reprod Biol Endocrinol       Date:  2021-06-21       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.